US2936141033 - ETTX (XNAS)
ENTASIS THERAPEUTICSCS HOLDINGS INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -62,05 % |
Firmenprofil zu ENTASIS THERAPEUTICSCS HOLDINGS INC Aktie
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts. Entasis Therapeutics Holdings Inc. operates as a subsidiary of Innoviva, Inc.
Unternehmensdaten zur ENTASIS THERAPEUTICSCS HOLDINGS INC Aktie
Name ENTASIS THERAPEUTICSCS HOLDINGS INC
Firma Entasis Therapeutics Holdings Inc.
Symbol ETTX
Website https://www.entasistx.com
Heimatbörse
NASDAQ
ISIN US2936141033
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Manoussos Perros
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 35 Gatehouse Dr, 02451 Waltham
IPO Datum 2018-09-26
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ETTX |
Weitere Aktien
Investoren die ENTASIS THERAPEUTICSCS HOLDINGS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024